Record Details

Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs

KRISHI: Publication and Data Inventory Repository

View Archive Info
 
 
Field Value
 
Title Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs
Not Available
 
Creator Binjawadagi B
Lakshmanappa YS
Longchao Z
Dhakal S
Hiremath J
Ouyang K
Shyu DL
Arcos J
Pengcheng S
Gilbertie A
Zuckermann F
Torrelles JB
Jackwood D
Fang Y
Renukaradhya GJ
 
Subject Lung Homogenate
Viral Surface Protein
Baculovirus Transfer Vector
PRRSV Strain
Porcine Alveolar Macrophage Cell
 
Description Not Available
Porcine reproductive and respiratory syndrome (PRRS) is a leading cause of economic burden to the pork industry worldwide. The routinely used modified live PRRS virus vaccine (PRRS-MLV) induces clinical protection, but it has safety concerns. Therefore, in an attempt to develop a safe and protective inactivated PRRSV vaccine, we generated PRRS-virus-like-particles (PRRS-VLPs) containing the viral surface proteins GP5-GP4-GP3-GP2a-M or GP5-M using a novel baculovirus expression system. Our in vitro results indicated that the desired PRRSV proteins were incorporated in both the VLPs preparations based on their reactivity in immunogold electron microscopy and ELISA. To boost their immunogenicity in pigs, we entrapped the PRRS-VLPs in PLGA nanoparticles and coadministered them intranasally with a potent adjuvant. We then evaluated their efficacy in pigs against a viral challenge using a virulent heterologous field isolate. Our results indicated that PRRS-VLPs induced an anamnestic immune response, since we observed boosted IgG and IFN-γ production in vaccinated and virus-challenged animals, but not during the pre-challenge period. Importantly, a two-log reduction in the lung viral load was detected in PRRS-VLP-vaccinated animals. In conclusion, we generated PRRS-VLPs containing up to five viral surface proteins and demonstrated their immunogenicity in pigs, but further studies are required to improve its immunogenicity and efficacy as a vaccine candidate.
Not Available
 
Date 2018-11-05T09:20:47Z
2018-11-05T09:20:47Z
2016-03-23
 
Type Research Paper
 
Identifier Not Available
1432-8798
http://krishi.icar.gov.in/jspui/handle/123456789/9348
 
Language English
 
Relation Not Available;
 
Publisher Springer